This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Anxiety Sensitivity Treatment for Heroin Users (ASTH-HR)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2010 by University of Maryland.
Recruitment status was:  Recruiting
Information provided by:
University of Maryland Identifier:
First received: August 23, 2010
Last updated: September 3, 2010
Last verified: September 2010
Anxiety Sensitivity Treatment for Heroin Users is a development project targeting mild and above levels of anxiety sensitivity that will involve the testing of a specialized protocol for improving treatment retention and outcomes for heroin dependent individuals in a residential substance use treatment. ASTH-HR will integrate established treatment modules such as Healthy Relationships, along with interoceptive exposure, affect management, and psycho-education exercises developed for anxiety prevention and treatment programs with standard substance use treatment.

Condition Intervention
Anxiety Behavioral: Anxiety sensitivity therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Novel Intervention for Drug Use and HIV Risk Among Anxiety Sensitive Heroin Users

Resource links provided by NLM:

Further study details as provided by University of Maryland:

Primary Outcome Measures:
  • Anxiety Sensitivity Index-3 [ Time Frame: 24 weeks ]

Secondary Outcome Measures:
  • Timeline Follow Back 90 days [ Time Frame: 24 weeks ]

Estimated Enrollment: 60
Study Start Date: October 2009
Estimated Study Completion Date: September 2011
Estimated Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Anxiety sensitivity therapy
    ASTH consists of 6 sessions of individual treatment, each lasting approximately 75 minutes over 3 weeks. In general, each session consists of the following components1) psychoeducation regarding the anxiety response, with a focus on increasing awareness of the ways in which the patient interprets or evaluates that response 2) assistance in developing healthy emotion regulation strategies that can be used to increase acceptance and tolerance of the anxiety response (including associated catastrophic thoughts), as well as understanding the consequences associated with avoidance or control of anxiety 3) a minimum of 3 interoceptive exercises tailored to activate feared anxiety-related sensations and 4) daily homework assignments (i.e., daily anxiety monitoring and interoceptive exercises).

Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • exhibit a score of 21 on a self-report measure of anxiety sensitivity
  • be in 28 days of residential substance use treatment.
  • meet criteria for current opioid dependence as determined by SCID interview administered at intake.

Exclusion Criteria:

  • evidence of limited mental competency
  • the inability to give informed, voluntary, written consent to participate
  • current psychosis
  • current bipolar disorder.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01196312

Contact: Carl W Lejuez, PhD (301)405-5932

United States, District of Columbia
Salvation Army Harbor Light Treatment Facilitiy Recruiting
Washington, District of Columbia, United States, 20002
Contact    202-269-6333      
Principal Investigator: Carl Lejuez, PhD         
Sponsors and Collaborators
University of Maryland
  More Information

Responsible Party: Dr. Carl W. Lejuez, Department of Psychology University Of Maryland, College Park Identifier: NCT01196312     History of Changes
Other Study ID Numbers: DA023384
Study First Received: August 23, 2010
Last Updated: September 3, 2010

Keywords provided by University of Maryland:
anxiety sensitivity

Additional relevant MeSH terms:
Anxiety Disorders
Mental Disorders
Analgesics, Opioid
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents processed this record on September 21, 2017